West Pharmaceutical Services (NYSE:WST) Upgraded at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of West Pharmaceutical Services (NYSE:WST – Free Report) from a hold rating to a buy rating in a report released on Friday, Marketbeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has $250.00 target price on the medical instruments supplier’s stock. Other equities research analysts have also recently issued research reports about […]